Best of Both Worlds: SOPs for Device Trials in Europe
This article was originally published in RAJ Devices
Nancy J Stark reports that navigating device clinical trials in Europe may require a hybrid procedure that uses both the ISO 14155 standard for devices and the pharmaceutical ICH-GCP guideline
You may also be interested in...
Guardant’s CEO anticipates accelerated adoption and reimbursement of its FDA-approved liquid biopsy assay and more biopharma partnerships.
Public Company Edition: The German mRNA-focused company could raise up to $245m based on its proposed price range, but investor interest could drive the offering’s total higher. Also, Perceptive launches another SPAC, Regeneron sells $2bn in debt and Biohaven secures up to $950m.
Agency commissioner appeals to AMA audience to communicate message that FDA review decisions are based on good science.